Search Results - drug development

3 Results Sort By:
Treatment of atrial fibrillation associated with obesity using endothelin receptor antagonists
Atrial fibrosis prevention in obese and overweight patients Overweight patients are at increased risk of atrial fibrillation (AF) and atrial fibrosis. Treatment of this group with endothelin receptor antagonists (ERAs) could reduce that risk and obviate the need for more invasive and expensive treatments for atrial fibrillation, such as ablation pr...
Published: 1/28/2018   |   Inventor(s):  
Keywords(s): Biology, Biopharmaceuticals, Cardiovascular Disease, Drug Delivery, Drug Development
Category(s): Medical, Biology, Biomedical, Biotechnology, Therapeutic
Clinical Trial Capability
Researchers who perform both clinical work and research in their specific fields of expertise are highly sort after by industry to study the latest therapies. They provide customers with credible, reliable and unbiased results which are highly regarded by regulators.The University of Adelaide's areas of expertise include:- Pain and Anaesthesia- Car...
Published: 10/27/2013   |   Inventor(s):  
Keywords(s): Addiction / Drug Dependency, Analytical Services, Anti-infectives, Assays, AutoImmune, Biology, Biomaterials, Biopharmaceuticals, Biosensing, Cancer, Cardiovascular Disease, CNS, Contraception, Diabetes, Drug Delivery, Drug Development, Endocrinology, Gastroenterology, Gastrointestinal, Gene/Cell Therapy, Genetic Disorders, Haematology, Hormone Therapy, Immunology, Infectious Disease, Inflammation, Medical Device, Mental Health, Metabolic Disease, Musculoskelatal, Neurology, Oncology, Ophthalmic, Osteo / Bone, Pathology, Pharmacogenetics, Pulmonary, Regenerative Medicine, Renal, Reproductive, Respiritory, Skin/Dermatological, Systems Biology, Urological, Vaccines
Category(s): Medical, Biomedical, Biotechnology, Dental, Devices, Diagnostic, Drug Delivery, Drug Discovery, Drug Screening, Gene Therapy, Genomics/Genetics, Nanotechnology, Therapeutic
Chemokine Receptor Inhibition and Anti-Tumour Immunity
Description of the Technology CCX-CKR expressed in malignant melanoma and many other metastatic cancers. Circumstantial evidence from the literature predicted that interfering with the expression and/or function of CCX-CKR would exacerbate melanoma growth and metastasis. To test this hypothesis, a series of experiments in the B16 murine melan...
Published: 10/28/2012   |   Inventor(s):  
Keywords(s): Cancer, Drug Development, Oncology, Vaccines
Category(s): Therapeutic, Medical, Biomedical, Biotechnology